The U.S. National Institute on Drug Abuse (NIDA) awarded a $24,620.00 firm fixed-price purchase order to Zaiput Flow Technologies LLC, a for-profit limited liability company that manufactures innovative separation tools for continuous flow chemistry applications in the pharmaceutical industry. The award, with a completion date of February 1, 2019, is for the acquisition of 4 membrane-based liquid-liquid/gas separators, a back pressure regulator, and related consumables. This award does not...
This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Bruker Spatial Biology, Inc., a for-profit manufacturer of advanced scientific instrumentation and related services. The $24,281 firm fixed-price contract is for the provision of transcriptomics panels to support patient sample experiments at the NHLBI lab. The contract is not designated as a set-aside. The award is associated with a $10,000,000 Blanket Purchase Agreement (BPA)...
<p>The National Heart Lung and Blood Institute (NHLBI), a civilian agency of the U.S. government, awarded a $6,000.00 firm fixed price purchase order to the American Institute For Medical & Biological Engineering Inc. for conference sponsorship fees. The award has no set-aside designation and was made on August 12, 2008 with a completion date of December 5, 2008. The contractor is registered in the System for Award Management (SAM.gov) with an expiration date of June 1, 2009.</p>
The National Heart Lung and Blood Institute (NHLBI) awarded a firm-fixed-price purchase order contract to Seahorse Bioscience, Inc. (Seahorse Labware) for an Extracellular Flux Analyzer. The $161,745.00 contract has a completion date of September 13, 2016 and was set aside for small businesses. The contract is not associated with a larger vehicle. The NHLBI is a component of the U.S. Department of Health and Human Services that conducts research to prevent and treat heart, lung, blood, and sleep...
The National Heart, Lung and Blood Institute of the National Institutes of Health awarded a $16,319.69 firm fixed price delivery order to Fisher Scientific Company L.L.C. under the company's Multiple Award Schedule contract with the General Services Administration. The delivery order is to provide a Milli-Q IQ 7000 purification system to the Laboratory of Cell and Tissue Morphodynamics as part of the Center for the Developmental and Perinatal Cardiology of the NHLBI. The period of performance is...
The National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) awarded a $24,898 firm fixed-price purchase order to Component Supply Co Inc. for custom catheter prototyping materials and iterations to develop a deep intramyocardial ablation microcatheter system for vintage (ventricular intramyocardial navigation for tachycardia ablation). This contract, which has an ultimate completion date of October 11, 2024, does not have a set-aside designation. The award is...
The National Heart Lung and Blood Institute (NHLBI), a civilian agency under the National Institutes of Health (NIH), awarded a $33,165.45 firm fixed-price purchase order to Boston Electronics Corporation, a for-profit company that specializes in advanced electro-optical components and systems. The contract is for the delivery of NADH/FAD+ fluorescence lifetime imaging and mScarlet oxygen probe equipment, which will likely be used in biomedical research supported by the NHLBI. Boston Electronics...
The National Heart, Lung and Blood Institute of the National Institutes of Health, Department of Health and Human Services, awarded a $224,000 purchase order to Cell Signaling Technology, Inc. of Danvers, Massachusetts for proteome analysis services. The one-year contract, running from August 2024 through August 2025, is for a firm fixed price and will be performed in Danvers. As part of its mission to advance scientific and medical achievements that eliminate preventable disease, the NHLBI...
The National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), awarded a $10,620 firm fixed price purchase order to Proteogenix, a for-profit manufacturer of biotechnology products and services. The contract provides additional laboratory screening services to support the development of novel gene therapy by the NHLBI's Center for Molecular Therapeutics and Bioanalytics (CMTB). This award is not associated with a larger contract vehicle and does not have...
This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Samyak Solutions, Inc., a small, minority-owned business based in Centreville, Virginia. The $54,858.22 firm fixed-price delivery order is to provide a Zetasizer Advance Series - Lab (Red Label) instrument to the NHLBI Laboratory of Regenerative Therapies for Inherited Blood Disorders, in order to characterize the biophysical parameters of lipid...